Prison TB study tests shorter prevention course
NCT ID NCT03089983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at ways to prevent tuberculosis (TB) in Malaysian prisoners, many of whom also had HIV, opioid addiction, or hepatitis. Researchers compared a standard 40-week TB prevention treatment with a shorter 12-week option. The goal was to see which approach worked better in a prison setting and to model cost-effective strategies for TB screening and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- isoniazid and rifapentine
- What this could lead to
- If successful, this could point toward more effective and shorter TB prevention strategies for high-risk prison populations.
- What could go wrong
- This is an observational and comparative study, not a large-scale trial. Results may not apply to other settings or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kajang Prison
Kajang, Selangor, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a robot help stroke survivors with HIV walk again?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can a targeted antibody stop severe hepatitis from destroying Children's livers?
- Can a Father-Focused program curb HIV, substance abuse, and violence?